Related Party Transactions (Details) (Parivid, LLC, USD $) In Millions, unless otherwise specified	1 Months Ended
Aug. 31, 2011	Apr. 30, 2007
Parivid, LLC
Related Party Transactions
Cash paid for acquisition of assets		$ 2.5
Contingent milestone payment in form of cash and/or stock, maximum		11.0
Payment related to enoxaparin sodium injection developed technology	$ 6.7
Amortization period of enoxaparin sodium injection developed technology	10 years

Amount of cash paid to acquire the entity.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 68

-Subparagraph f(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Name:	us-gaap_BusinessAcquisitionCostOfAcquiredEntityCashPaid
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant